Live Breaking News & Updates on Treg Crosstalk Improves

Checkpoint immunotherapy utilizing PD-1 blockade has become the standard of care for metastatic melanoma. While this treatment is effective in 40% of patients, the other 60% develop resistance, leading to tumor regrowth. A multidisciplinary research team led by the University of California, Irvine has identified a new strategy that could enhance the therapeutic effectiveness of this therapy by targeting the communication between immune cells within the tumor. ....

Irvine School , United States , Francesco Marangoni , Shannon Geels , Multiscale Cell Fate Research , Uc Irvine School Of Medicine , University Of California , Saint John Cancer Institute In Santa Monica , Department Of Physiology Biophysics , University Of Alabama At Birmingham , Institute For Immunology , Harvard Medical School , Cancer Cell , Complex Biological Systems , Simons Center , Saint John , Cancer Institute , Santa Monica , Massachusetts General Hospital , Harvard Medical , Treg Crosstalk Improves ,